Cerebro Spinal Fluid Management - Medical Devices Pipeline Assessment, 2016 - GlobalData

Cerebro Spinal Fluid Management - Medical Devices Pipeline Assessment, 2016

Cerebro Spinal Fluid Management - Medical Devices Pipeline Assessment, 2016 - GlobalData
Cerebro Spinal Fluid Management - Medical Devices Pipeline Assessment, 2016
Published Nov 01, 2016
81 pages — Published Nov 01, 2016
Price US$ 4,000.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GlobalData's Medical Devices sector report, Cerebro Spinal Fluid Management - Medical Devices Pipeline Assessment, 2016' provides an overview of Cerebro Spinal Fluid Management currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cerebro Spinal Fluid Management pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Cerebro Spinal Fluid Management under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Cerebro Spinal Fluid Management and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Cerebro Spinal Fluid Management under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date

  
Source:
Document ID
GDME0247EPD
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
1 Table of Contents26
  1.1 List of Tables52
  1.2 List of Figures71
2 Introduction81
  2.1 CSF Management Overview81
3 Products under Development96
  3.1 Cerebro Spinal Fluid Management - Pipeline Products by Stage of Development91
  3.2 Cerebro Spinal Fluid Management - Pipeline Products by Segment101
  3.3 Cerebro Spinal Fluid Management - Pipeline Products by Territory111
  3.4 Cerebro Spinal Fluid Management - Pipeline Products by Regulatory Path121
  3.5 Cerebro Spinal Fluid Management - Pipeline Products by Estimated Approval Date131
  3.6 Cerebro Spinal Fluid Management - Ongoing Clinical Trials141
4 Cerebro Spinal Fluid Management - Pipeline Products under Development by Companies154
  4.1 Cerebro Spinal Fluid Management Companies - Pipeline Products by Stage of Development152
  4.2 Cerebro Spinal Fluid Management - Pipeline Products by Stage of Development172
5 Cerebro Spinal Fluid Management Companies and Product Overview1940
  5.1 Alcyone Lifesciences, Inc. Company Overview191
    5.1.1 Alcyone Lifesciences, Inc. Pipeline Products &Ongoing Clinical Trials Overview193
  5.2 Aqueduct Neurosciences Company Overview221
    5.2.1 Aqueduct Neurosciences Pipeline Products &Ongoing Clinical Trials Overview222
  5.3 Arkis BioSciences Company Overview241
    5.3.1 Arkis BioSciences Pipeline Products &Ongoing Clinical Trials Overview241
  5.4 Beckersmith Medical, Inc. Company Overview251
    5.4.1 Beckersmith Medical, Inc. Pipeline Products &Ongoing Clinical Trials Overview251
  5.5 Biosan Medical Ltd. Company Overview261
    5.5.1 Biosan Medical Ltd. Pipeline Products &Ongoing Clinical Trials Overview262
  5.6 Georgia Institute of Technology Company Overview281
    5.6.1 Georgia Institute of Technology Pipeline Products &Ongoing Clinical Trials Overview282
  5.7 H-Cubed Inc. Company Overview301
    5.7.1 H-Cubed Inc. Pipeline Products &Ongoing Clinical Trials Overview301
  5.8 Integra LifeSciences Holdings Corporation Company Overview311
    5.8.1 Integra LifeSciences Holdings Corporation Pipeline Products &Ongoing Clinical Trials Overview314
  5.9 InVivo Therapeutics Corporation Company Overview351
    5.9.1 InVivo Therapeutics Corporation Pipeline Products &Ongoing Clinical Trials Overview353
  5.10 Kerecis ehf Company Overview381
    5.10.1 Kerecis ehf Pipeline Products &Ongoing Clinical Trials Overview381
  5.11 Microbot Medical, Ltd. Company Overview391
    5.11.1 Microbot Medical, Ltd. Pipeline Products &Ongoing Clinical Trials Overview392
  5.12 Nanonerve Inc. Company Overview411
    5.12.1 Nanonerve Inc. Pipeline Products &Ongoing Clinical Trials Overview411
  5.13 NeuraMedica, LLC Company Overview421
    5.13.1 NeuraMedica, LLC Pipeline Products &Ongoing Clinical Trials Overview421
  5.14 NexGen Medical Systems, Inc. Company Overview431
    5.14.1 NexGen Medical Systems, Inc. Pipeline Products &Ongoing Clinical Trials Overview431
  5.15 Sree Chitra Tirunal Institute for Medical Sciences &Technology Company Overview441
    5.15.1 Sree Chitra Tirunal Institute for Medical Sciences &Technology Pipeline Products &Ongoing Clinical Trials Overview442
  5.16 System Science Inc. Company Overview461
    5.16.1 System Science Inc. Pipeline Products &Ongoing Clinical Trials Overview462
  5.17 University Hospital Zurich Company Overview481
    5.17.1 University Hospital Zurich Pipeline Products &Ongoing Clinical Trials Overview482
  5.18 University of Rochester Company Overview501
    5.18.1 University of Rochester Pipeline Products &Ongoing Clinical Trials Overview501
  5.19 University of South Florida Company Overview511
    5.19.1 University of South Florida Pipeline Products &Ongoing Clinical Trials Overview512
  5.20 University of Wisconsin Madison Company Overview531
    5.20.1 University of Wisconsin Madison Pipeline Products &Ongoing Clinical Trials Overview532
  5.21 Vivonics, Inc. Company Overview551
    5.21.1 Vivonics, Inc. Pipeline Products &Ongoing Clinical Trials Overview552
  5.22 Wayne State University Company Overview571
    5.22.1 Wayne State University Pipeline Products &Ongoing Clinical Trials Overview572
6 Cerebro Spinal Fluid Management- Recent Developments5919
  6.1 Oct 26, 2016: LeMaitre Q3 2016 Record Sales $23.2 mm (+22%), Record Op. Income $5.3 mm (+61%)591
  6.2 Oct 12, 2016: HyperBranch Medical Wins Decision Against Integra Lifesciences591
  6.3 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services601
  6.4 Aug 31, 2016: Cook Medical Names Jean-Marc Creissel Vice President of Operations in Greater China611
  6.5 Aug 25, 2016: Medtronic Reports First Quarter Financial Results613
  6.6 Aug 15, 2016: Studies Show That the Kerecis Fish Skin Reduces Infections and Preserves Tissue Viability641
  6.7 Aug 15, 2016: StemCells to Acquire Microbot Medical641
  6.8 Aug 11, 2016: InVivo Therapeutics Appoints Pamela Stahl as Chief Commercial Officer651
  6.9 Aug 09, 2016: Alcyone Lifesciences, Announces Allowance of First Patent Related to ReFlow System for the Treatment of Hydrocephalus661
  6.10 Aug 04, 2016: InVivo Therapeutics Reports 2016 Second Quarter Financial Results and Business Update671
  6.11 Aug 02, 2016: Alcyone Lifesciences Announces Clinical Use of the ReFlow System for the Treatment of Hydrocephalus681
  6.12 Jul 28, 2016: Integra LifeSciences Reports Second Quarter 2016 Financial Results682
  6.13 Jul 27, 2016: LeMaitre Q2 2016 Record Sales $22.4mm (+13%), Record Op. Income $3.8mm (+35%)701
  6.14 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic701
  6.15 Jun 24, 2016: Arkis BioSciences Raises USD3.4 Million in Series A Venture Financing711
  6.16 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day711
  6.17 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results713
  6.18 May 02, 2016: Medtronic Expands MRI-Compatible Portfolio With FDA Clearance Of StrataMR Shunt System741
  6.19 Apr 27, 2016: Integra LifeSciences Reports First Quarter 2016 Financial Results742
  6.20 Feb 25, 2016: Integra LifeSciences Reports Fourth Quarter and Full Year 2015 Financial Results and Issues 2016 Full Year Guidance761
  6.21 Nov 03, 2015: Integra LifeSciences Reports Third Quarter 2015 Financial Results771
7 Appendix784
  7.1 Methodology782
  7.2 About GlobalData801
  7.3 Contact Us811
  7.4 Disclaimer811

Table Of Contents

GlobalData—GlobalData uses proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries.

About the Author


Cite this Report

  
MLA:
GlobalData. "Cerebro Spinal Fluid Management - Medical Devices Pipeline Assessment, 2016" Nov 01, 2016. Alacra Store. May 07, 2025. <http://www.alacrastore.com/storecontent/GlobalData/Cerebro-Spinal-Fluid-Management-Medical-Devices-Pipeline-Assessment-2016-2085-24041>
  
APA:
GlobalData. (2016). Cerebro Spinal Fluid Management - Medical Devices Pipeline Assessment, 2016 Nov 01, 2016. New York, NY: Alacra Store. Retrieved May 07, 2025 from <http://www.alacrastore.com/storecontent/GlobalData/Cerebro-Spinal-Fluid-Management-Medical-Devices-Pipeline-Assessment-2016-2085-24041>
  
US$ 4,000.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.